Event Notification Report for May 10, 2023
U.S. Nuclear Regulatory Commission
Operations Center
EVENT REPORTS FOR
05/09/2023 - 05/10/2023
EVENT NUMBERS
56633
56633
Hospital
Event Number: 56633
Rep Org: North Kansas City Hospital
Licensee: North Kansas City Hospital
Region: 3
City: Kansas City State: MO
County:
License #: 24-17561-01
Agreement: N
Docket:
NRC Notified By: Karen Hopping
HQ OPS Officer: Karen Cotton-Gross
Licensee: North Kansas City Hospital
Region: 3
City: Kansas City State: MO
County:
License #: 24-17561-01
Agreement: N
Docket:
NRC Notified By: Karen Hopping
HQ OPS Officer: Karen Cotton-Gross
Notification Date: 07/21/2023
Notification Time: 17:00 [ET]
Event Date: 05/10/2023
Event Time: 00:00 [CDT]
Last Update Date: 07/21/2023
Notification Time: 17:00 [ET]
Event Date: 05/10/2023
Event Time: 00:00 [CDT]
Last Update Date: 07/21/2023
Emergency Class: Non Emergency
10 CFR Section:
35.3047(a) - Embryo/Fetus Dose > 50 Msv
10 CFR Section:
35.3047(a) - Embryo/Fetus Dose > 50 Msv
Person (Organization):
Hills, David (R3DO)
NMSS_EVENTS_NOTIFICATION (EMAIL)
Williams, Kevin (MSST-DIR)
Hills, David (R3DO)
NMSS_EVENTS_NOTIFICATION (EMAIL)
Williams, Kevin (MSST-DIR)
DOSE TO AN EMBRYO
The following information is a summary of a phone call with the North Kansas City Hospital Radiation Safety Officer (RSO):
On May 10, 2023, a nuclear medicine tech administered 125.7 mCi of I-131 to a patient for the thyroid cancer ablation at North Kansas City Hospital. The patient had received a pregnancy test on May 8, 2023, which was negative.
On July 21, 2023, the hospital was notified that the patient was pregnant with an estimated fetal age of 7-10 weeks which would have had the patient pregnant at the time of administration, or shortly thereafter. This event is being reported because of the potential for a dose to the embryo.
At this time there are no known negative effects to the patient.
The following information is a summary of a phone call with the North Kansas City Hospital Radiation Safety Officer (RSO):
On May 10, 2023, a nuclear medicine tech administered 125.7 mCi of I-131 to a patient for the thyroid cancer ablation at North Kansas City Hospital. The patient had received a pregnancy test on May 8, 2023, which was negative.
On July 21, 2023, the hospital was notified that the patient was pregnant with an estimated fetal age of 7-10 weeks which would have had the patient pregnant at the time of administration, or shortly thereafter. This event is being reported because of the potential for a dose to the embryo.
At this time there are no known negative effects to the patient.